Gastric Balloon Market Growing at a CAGR of 9.7% - Leading companies like ENDALIS, MEDSIL, Obalon Therapeutics, Silimed, Allurion Technologies

Gastric balloons are being preferred for weight loss during recent days. Unlike other procedures for weight loss, the gastric balloons are non-invasive methods for managing weight loss. The gastric balloon is placed through the mouth and is pushed down the esophagus, while it is in its least dilated form. Once the balloon reaches the stomach, it is filled with the saline or gas with the help of a tube, which is removed out once the balloon has been placed. These balloons are inserted in the stomach for around 6 months in order to obtain proper weight loss. The growth of the Gastric Balloon in healthcare market is attributed to the rising preference for minimally invasive methods for weight loss are the key driving factors for the growth of the market in the forecast period. However, the growth of the market is restrained by factors such as, lack of reimbursement and the side effects or complications caused due to the use of gastric balloons.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003016/?utm_source=OpenPR&utm_medium=10144

The major players operating in the gastric balloon market include, Apollo Endosurgery, Inc., Allurion Technologies ENDALIS, Helioscopie Medical Implants, LEXEL SRL, MEDSIL, Obalon Therapeutics, Inc., ReShape Lifesciences, Inc., Silimed, and Spatz FGIA, Inc., among others. Approvals the are prominent parameters by industry players leading strategies undertaken by key market players.

Global gastric balloon market, based on product was segmented as, single gastric balloons, dual gastric balloons and triple gastric balloons. In 2018, the single gastric balloon held the largest share of the market, by product. Additionally, the segment is also expected to grow at the fastest CAGR during the forecast period owing to better benefits offered as compared to the dual and triple gastric balloon, also the implantation of a single balloon causes less discomfort, leading to its rising preference.

The Gastric Balloon in healthcare market was valued at US$ 67.3 million in 2018 and it is projected to reach US$ 152.1 million by 2027; it is expected to grow at a CAGR of 9.7% from 2019 to 2027.

Gastric balloons are implanted into the body through endoscopy and offers a weight loss upto 7 to 8 pounds. The Orbera gastric balloon offers a weight loss of 7 pounds on average. Whereas, the Obalon gastric balloon offers an average of 7.4 pounds or 3.42 percent of their total body weight. The benefits offered by gastric balloon along with prevalence of obesity worldwide is anticipated to fuel the growth of the gastric balloons market during the forecast period.

The endoscopic intragastric balloon treatment is a non-surgical method to help lose weight in patients who suffer from obesity or morbid obesity. It is an endoscopic procedure, in which a balloon is inserted in the stomach, which occupies about half of the stomach's space. The balloon remains in the stomach for a maximum of six months and it is meant to increase the feeling of satiety and limit food intake.

Place an order copy of this report @ https://www.theinsightpartners.com/buy/TIPRE00003016/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.